25 XP   0   0   10

Laboratorios Richmond SACIF
Buy, Hold or Sell?

Let's analyse Laboratorios Richmond SACIF together

PenkeI guess you are interested in Laboratorios Richmond SACIF. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Laboratorios Richmond SACIF. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Laboratorios Richmond SACIF

I send you an email if I find something interesting about Laboratorios Richmond SACIF.

Quick analysis of Laboratorios Richmond SACIF (30 sec.)










What can you expect buying and holding a share of Laboratorios Richmond SACIF? (30 sec.)

How much money do you get?

How much money do you get?
ARS0.00
When do you have the money?
1 year
How often do you get paid?
52.5%

What is your share worth?

Current worth
ARS217.82
Expected worth in 1 year
ARS321.02
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
ARS107.20
Return On Investment
12.6%

For what price can you sell your share?

Current Price per Share
ARS849.50
Expected price per share
ARS664.00 - ARS1,235
How sure are you?
50%

1. Valuation of Laboratorios Richmond SACIF (5 min.)




Live pricePrice per Share (EOD)

ARS849.50

Intrinsic Value Per Share

ARS-3,004.99 - ARS-3,579.70

Total Value Per Share

ARS-2,787.18 - ARS-3,361.89

2. Growth of Laboratorios Richmond SACIF (5 min.)




Is Laboratorios Richmond SACIF growing?

Current yearPrevious yearGrowGrow %
How rich?$21.1m$8.6m$7.7m47.3%

How much money is Laboratorios Richmond SACIF making?

Current yearPrevious yearGrowGrow %
Making money-$1m$364.5k-$1.4m-134.7%
Net Profit Margin-16.4%5.3%--

How much money comes from the company's main activities?

3. Financial Health of Laboratorios Richmond SACIF (5 min.)




What can you expect buying and holding a share of Laboratorios Richmond SACIF? (5 min.)

Welcome investor! Laboratorios Richmond SACIF's management wants to use your money to grow the business. In return you get a share of Laboratorios Richmond SACIF.

What can you expect buying and holding a share of Laboratorios Richmond SACIF?

First you should know what it really means to hold a share of Laboratorios Richmond SACIF. And how you can make/lose money.

Speculation

The Price per Share of Laboratorios Richmond SACIF is ARS849.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Laboratorios Richmond SACIF.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Laboratorios Richmond SACIF, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ARS217.82. Based on the TTM, the Book Value Change Per Share is ARS25.80 per quarter. Based on the YOY, the Book Value Change Per Share is ARS15.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ARS1.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Laboratorios Richmond SACIF.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per Share
Usd Eps-0.030.0%-0.010.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.050.0%0.030.0%0.020.0%0.010.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.050.0%0.030.0%0.020.0%0.010.0%0.010.0%
Usd Price Per Share0.62-0.54-0.30-0.25-0.13-
Price to Earnings Ratio-5.09-14.09--9.57--5.94--2.04-
Price-to-Total Gains Ratio13.65-18.11-15.67-26.53-22.15-
Price to Book Ratio2.36-2.71-2.88-3.13-1.62-
Price-to-Total Gains Ratio13.65-18.11-15.67-26.53-22.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.0194
Number of shares980
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.01
Usd Total Gains Per Share0.030.01
Gains per Quarter (980 shares)31.5210.19
Gains per Year (980 shares)126.0640.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1512111633831
2924324257672
3143643688115113
41948549410153154
52360762013191195
62872874616229236
73385087218267277
83897199821305318
9421092112423344359
10471214125026382400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%5.07.00.041.7%9.011.00.045.0%24.011.05.060.0%26.011.06.060.5%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%32.08.00.080.0%33.09.01.076.7%
Dividend per Share1.00.03.025.0%9.00.03.075.0%11.00.09.055.0%21.00.019.052.5%22.00.021.051.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%34.06.00.085.0%35.07.01.081.4%

Fundamentals of Laboratorios Richmond SACIF

About Laboratorios Richmond SACIF

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is headquartered in Buenos Aires, Argentina.

Fundamental data was last updated by Penke on 2024-03-12 16:20:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Laboratorios Richmond SACIF.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Laboratorios Richmond SACIF earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -36.4% means that $-0.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Laboratorios Richmond SACIF:

  • The MRQ is -36.4%. The company is making a huge loss. -2
  • The TTM is -16.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-36.4%TTM-16.4%-20.1%
TTM-16.4%YOY5.3%-21.7%
TTM-16.4%5Y-2.7%-13.7%
5Y-2.7%10Y0.9%-3.5%
1.1.2. Return on Assets

Shows how efficient Laboratorios Richmond SACIF is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Laboratorios Richmond SACIF generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Laboratorios Richmond SACIF:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-1.4%-1.3%
TTM-1.4%YOY1.1%-2.5%
TTM-1.4%5Y0.0%-1.3%
5Y0.0%10Y0.6%-0.7%
1.1.3. Return on Equity

Shows how efficient Laboratorios Richmond SACIF is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • -11.8% Return on Equity means Laboratorios Richmond SACIF generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Laboratorios Richmond SACIF:

  • The MRQ is -11.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-5.9%-5.9%
TTM-5.9%YOY5.2%-11.1%
TTM-5.9%5Y-0.2%-5.7%
5Y-0.2%10Y2.7%-2.9%

1.2. Operating Efficiency of Laboratorios Richmond SACIF.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Laboratorios Richmond SACIF is operating .

  • Measures how much profit Laboratorios Richmond SACIF makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Laboratorios Richmond SACIF:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.3%-10.3%
TTM10.3%YOY13.4%-3.1%
TTM10.3%5Y13.1%-2.9%
5Y13.1%10Y6.6%+6.6%
1.2.2. Operating Ratio

Measures how efficient Laboratorios Richmond SACIF is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are $1.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Laboratorios Richmond SACIF:

  • The MRQ is 1.879. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.485. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.879TTM1.485+0.394
TTM1.485YOY1.475+0.010
TTM1.4855Y1.424+0.061
5Y1.42410Y0.943+0.481

1.3. Liquidity of Laboratorios Richmond SACIF.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Laboratorios Richmond SACIF is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.07 means the company has $1.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Laboratorios Richmond SACIF:

  • The MRQ is 1.067. The company is just able to pay all its short-term debts.
  • The TTM is 1.306. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.067TTM1.306-0.239
TTM1.306YOY1.586-0.280
TTM1.3065Y1.394-0.088
5Y1.39410Y0.697+0.697
1.3.2. Quick Ratio

Measures if Laboratorios Richmond SACIF is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.36 means the company can pay off $0.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Laboratorios Richmond SACIF:

  • The MRQ is 0.359. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.599. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.359TTM0.599-0.240
TTM0.599YOY0.747-0.148
TTM0.5995Y0.633-0.034
5Y0.63310Y0.685-0.052

1.4. Solvency of Laboratorios Richmond SACIF.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Laboratorios Richmond SACIF assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Laboratorios Richmond SACIF to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.77 means that Laboratorios Richmond SACIF assets are financed with 77.3% credit (debt) and the remaining percentage (100% - 77.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Laboratorios Richmond SACIF:

  • The MRQ is 0.773. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.753. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.773TTM0.753+0.020
TTM0.753YOY0.754-0.001
TTM0.7535Y0.673+0.080
5Y0.67310Y0.708-0.035
1.4.2. Debt to Equity Ratio

Measures if Laboratorios Richmond SACIF is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 344.3% means that company has $3.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Laboratorios Richmond SACIF:

  • The MRQ is 3.443. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.098. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.443TTM3.098+0.345
TTM3.098YOY3.144-0.046
TTM3.0985Y2.337+0.761
5Y2.33710Y2.797-0.460

2. Market Valuation of Laboratorios Richmond SACIF

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Laboratorios Richmond SACIF generates.

  • Above 15 is considered overpriced but always compare Laboratorios Richmond SACIF to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.09 means the investor is paying $-5.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Laboratorios Richmond SACIF:

  • The EOD is -8.390. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.086. Based on the earnings, the company is expensive. -2
  • The TTM is 14.090. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-8.390MRQ-5.086-3.304
MRQ-5.086TTM14.090-19.176
TTM14.090YOY-9.575+23.664
TTM14.0905Y-5.936+20.026
5Y-5.93610Y-2.038-3.898
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Laboratorios Richmond SACIF:

  • The EOD is -3.667. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.223. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.918. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.667MRQ-2.223-1.444
MRQ-2.223TTM-3.918+1.695
TTM-3.918YOY-2.218-1.700
TTM-3.9185Y2.045-5.963
5Y2.04510Y0.881+1.164
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Laboratorios Richmond SACIF is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Laboratorios Richmond SACIF:

  • The EOD is 3.900. Based on the equity, the company is fair priced.
  • The MRQ is 2.364. Based on the equity, the company is underpriced. +1
  • The TTM is 2.713. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.900MRQ2.364+1.536
MRQ2.364TTM2.713-0.348
TTM2.713YOY2.885-0.172
TTM2.7135Y3.129-0.416
5Y3.12910Y1.623+1.507
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Laboratorios Richmond SACIF compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--37.73325.802+46%15.248+147%8.114+365%5.298+612%
Book Value Per Share--217.815169.794+28%89.435+144%73.563+196%45.114+383%
Current Ratio--1.0671.306-18%1.586-33%1.394-23%0.697+53%
Debt To Asset Ratio--0.7730.753+3%0.754+3%0.673+15%0.708+9%
Debt To Equity Ratio--3.4433.098+11%3.144+9%2.337+47%2.797+23%
Dividend Per Share---0.997-100%1.069-100%0.552-100%0.579-100%
Eps---25.313-10.787-57%1.895-1436%-2.175-91%-0.752-97%
Free Cash Flow Per Share---57.915-36.494-37%-34.322-41%-15.872-73%-10.220-82%
Free Cash Flow To Equity Per Share---57.915-15.599-73%-15.106-74%-6.823-88%-2.421-96%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Intrinsic Value_10Y_max---3579.705--------
Intrinsic Value_10Y_min---3004.992--------
Intrinsic Value_1Y_max---131.958--------
Intrinsic Value_1Y_min---129.482--------
Intrinsic Value_3Y_max---569.294--------
Intrinsic Value_3Y_min---540.006--------
Intrinsic Value_5Y_max---1214.976--------
Intrinsic Value_5Y_min---1112.836--------
Market Cap12035036400.000-246%41587015805.00036620799354.500+14%20430126211.000+104%16865298513.713+147%8474513332.856+391%
Net Profit Margin---0.364-0.164-55%0.053-789%-0.027-93%0.009-4326%
Operating Margin---0.103-100%0.134-100%0.131-100%0.066-100%
Operating Ratio--1.8791.485+27%1.475+27%1.424+32%0.943+99%
Pb Ratio3.900+39%2.3642.713-13%2.885-18%3.129-24%1.623+46%
Pe Ratio-8.390-65%-5.08614.090-136%-9.575+88%-5.936+17%-2.038-60%
Price Per Share849.500+39%515.000453.500+14%253.000+104%210.353+145%108.131+376%
Price To Free Cash Flow Ratio-3.667-65%-2.223-3.918+76%-2.2180%2.045-209%0.881-352%
Price To Total Gains Ratio22.513+39%13.64918.106-25%15.671-13%26.528-49%22.146-38%
Quick Ratio--0.3590.599-40%0.747-52%0.633-43%0.685-48%
Return On Assets---0.026-0.014-48%0.011-331%0.000-98%0.006-532%
Return On Equity---0.118-0.059-50%0.052-326%-0.002-98%0.027-539%
Total Gains Per Share--37.73326.799+41%16.317+131%8.665+335%5.878+542%
Usd Book Value--21106708.78416453346.383+28%8666402.765+144%6815079.223+210%3549201.921+495%
Usd Book Value Change Per Share--0.0450.031+46%0.018+147%0.010+365%0.006+612%
Usd Book Value Per Share--0.2610.204+28%0.107+144%0.088+196%0.054+383%
Usd Dividend Per Share---0.001-100%0.001-100%0.001-100%0.001-100%
Usd Eps---0.030-0.013-57%0.002-1436%-0.003-91%-0.001-97%
Usd Free Cash Flow---5612107.333-3536331.549-37%-3325867.718-41%-1431372.628-74%-711077.645-87%
Usd Free Cash Flow Per Share---0.069-0.044-37%-0.041-41%-0.019-73%-0.012-82%
Usd Free Cash Flow To Equity Per Share---0.069-0.019-73%-0.018-74%-0.008-88%-0.003-96%
Usd Market Cap14442043.680-246%49904418.96643944959.225+14%24516151.453+104%20238358.216+147%10169415.999+391%
Usd Price Per Share1.019+39%0.6180.544+14%0.304+104%0.252+145%0.130+376%
Usd Profit---2452904.982-1050574.840-57%364551.129-773%-117673.647-95%-53132.150-98%
Usd Revenue--6730290.0256248125.292+8%5433487.818+24%3451556.538+95%1839490.830+266%
Usd Total Gains Per Share--0.0450.032+41%0.020+131%0.010+335%0.007+542%
 EOD+4 -4MRQTTM+13 -22YOY+13 -225Y+13 -2210Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Laboratorios Richmond SACIF based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.390
Price to Book Ratio (EOD)Between0-13.900
Net Profit Margin (MRQ)Greater than0-0.364
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.359
Current Ratio (MRQ)Greater than11.067
Debt to Asset Ratio (MRQ)Less than10.773
Debt to Equity Ratio (MRQ)Less than13.443
Return on Equity (MRQ)Greater than0.15-0.118
Return on Assets (MRQ)Greater than0.05-0.026
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Laboratorios Richmond SACIF based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.150
Ma 20Greater thanMa 50826.775
Ma 50Greater thanMa 100910.120
Ma 100Greater thanMa 200810.475
OpenGreater thanClose854.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Retained Earnings  2,654,861-219,4612,435,400-2,161,748273,6522,510,4092,784,061-6,022,170-3,238,108
Operating Income  108,4561,316,4701,424,926-816,607608,319-540,25568,064-981,825-913,762



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in ARS. All numbers in thousands.

Summary
Total Assets77,434,627
Total Liabilities59,845,703
Total Stockholder Equity17,383,521
 As reported
Total Liabilities 59,845,703
Total Stockholder Equity+ 17,383,521
Total Assets = 77,434,627

Assets

Total Assets77,434,627
Total Current Assets19,146,342
Long-term Assets58,288,285
Total Current Assets
Cash And Cash Equivalents 400,806
Short-term Investments 213,093
Net Receivables 6,230,839
Inventory 8,934,662
Total Current Assets  (as reported)19,146,342
Total Current Assets  (calculated)15,779,400
+/- 3,366,942
Long-term Assets
Property Plant Equipment 47,109,824
Goodwill 2,058,835
Intangible Assets 7,982,542
Long-term Assets  (as reported)58,288,285
Long-term Assets  (calculated)57,151,201
+/- 1,137,084

Liabilities & Shareholders' Equity

Total Current Liabilities17,945,621
Long-term Liabilities41,900,082
Total Stockholder Equity17,383,521
Total Current Liabilities
Short Long Term Debt 5,790,879
Accounts payable 10,339,408
Other Current Liabilities 73
Total Current Liabilities  (as reported)17,945,621
Total Current Liabilities  (calculated)16,130,360
+/- 1,815,261
Long-term Liabilities
Long term Debt 3,908,865
Capital Lease Obligations Min Short Term Debt216,890
Long-term Liabilities Other 34,895
Long-term Liabilities  (as reported)41,900,082
Long-term Liabilities  (calculated)4,160,650
+/- 37,739,432
Total Stockholder Equity
Total Stockholder Equity (as reported)17,383,521
Total Stockholder Equity (calculated)0
+/- 17,383,521
Other
Capital Stock4,621,697
Common Stock Shares Outstanding 80,751
Net Debt 9,298,938
Net Invested Capital 27,083,265
Net Working Capital 1,200,721
Property Plant and Equipment Gross 53,942,232



Balance Sheet

Currency in ARS. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312011-12-312010-12-312009-12-312008-12-312008-09-302007-09-302006-09-30
> Total Assets 
56,356
77,583
100,634
107,007
127,840
135,779
159,025
270,955
276,743
276,743
290,686
287,372
315,091
323,549
357,608
385,658
387,299
391,705
400,815
532,834
556,555
640,283
724,917
861,132
726,253
779,149
912,391
1,552,641
1,637,185
1,821,701
2,402,981
2,705,186
2,805,766
2,948,371
3,807,181
5,134,618
5,260,627
5,845,090
6,986,402
8,133,335
9,254,840
12,165,119
24,167,525
25,693,158
26,062,569
30,899,929
33,553,373
40,720,110
47,570,398
58,907,378
77,434,627
77,434,62758,907,37847,570,39840,720,11033,553,37330,899,92926,062,56925,693,15824,167,52512,165,1199,254,8408,133,3356,986,4025,845,0905,260,6275,134,6183,807,1812,948,3712,805,7662,705,1862,402,9811,821,7011,637,1851,552,641912,391779,149726,253861,132724,917640,283556,555532,834400,815391,705387,299385,658357,608323,549315,091287,372290,686276,743276,743270,955159,025135,779127,840107,007100,63477,58356,356
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,967,306
1,914,169
1,894,278
2,571,194
3,287,659
3,263,874
3,591,461
4,519,380
5,371,511
5,406,240
7,750,533
10,771,693
15,434,862
11,898,535
13,723,575
12,314,790
14,040,135
14,035,121
16,163,176
19,146,342
19,146,34216,163,17614,035,12114,040,13512,314,79013,723,57511,898,53515,434,86210,771,6937,750,5335,406,2405,371,5114,519,3803,591,4613,263,8743,287,6592,571,1941,894,2781,914,1691,967,3060000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
501,119
347,465
258,089
350,686
217,146
310,788
500,976
315,168
493,831
516,623
404,284
1,597,793
4,666,788
2,223,395
752,939
1,625,507
1,255,852
805,126
1,103,850
400,806
400,8061,103,850805,1261,255,8521,625,507752,9392,223,3954,666,7881,597,793404,284516,623493,831315,168500,976310,788217,146350,686258,089347,465501,1190000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
481
799
1,148
3,668
1,720
1,188
1,085
357,776
345,707
347,005
532,356
85,949
2,693,158
1,815,837
1,778,922
1,297,585
1,433,968
745,570
188,186
213,093
213,093188,186745,5701,433,9681,297,5851,778,9221,815,8372,693,15885,949532,356347,005345,707357,7761,0851,1881,7203,6681,1487994810000000000000000000000000000000
       Net Receivables 
16,278
24,723
24,876
27,233
31,007
35,816
46,019
96,359
105,744
105,744
114,664
111,643
126,968
134,815
156,568
192,546
180,550
185,857
173,047
267,087
262,666
267,879
311,128
498,253
338,047
329,962
406,844
512,300
653,201
690,781
885,401
785,003
616,057
678,506
958,190
1,959,409
1,852,293
1,672,216
2,159,626
2,936,487
1,925,213
2,691,864
2,496,087
4,004,511
3,296,744
6,481,812
3,987,176
5,778,523
6,145,442
7,215,143
6,230,839
6,230,8397,215,1436,145,4425,778,5233,987,1766,481,8123,296,7444,004,5112,496,0872,691,8641,925,2132,936,4872,159,6261,672,2161,852,2931,959,409958,190678,506616,057785,003885,401690,781653,201512,300406,844329,962338,047498,253311,128267,879262,666267,087173,047185,857180,550192,546156,568134,815126,968111,643114,664105,744105,74496,35946,01935,81631,00727,23324,87624,72316,278
       Other Current Assets 
918
888
15,252
16,553
13,310
953
606
498
0
0
0
0
0
0
0
0
0
0
0
4,546
18,756
9,874
14,311
14,666
11,873
12,404
24,376
12,994
28,038
32,646
20,857
150,080
180,388
124,871
172,835
178,477
197,338
248,894
421,935
287,748
546,618
1,191,245
372,305
437,161
293,088
296,553
427,687
531,306
634,040
439,866
0
0439,866634,040531,306427,687296,553293,088437,161372,3051,191,245546,618287,748421,935248,894197,338178,477172,835124,871180,388150,08020,85732,64628,03812,99424,37612,40411,87314,66614,3119,87418,7564,5460000000000049860695313,31016,55315,252888918
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
891,597
1,054,093
1,235,987
1,846,959
1,996,753
2,253,630
2,467,021
3,168,386
3,848,600
4,414,586
13,395,832
10,258,296
14,164,034
17,176,354
21,238,583
26,679,974
33,535,276
42,744,202
58,288,285
58,288,28542,744,20233,535,27626,679,97421,238,58317,176,35414,164,03410,258,29613,395,8324,414,5863,848,6003,168,3862,467,0212,253,6301,996,7531,846,9591,235,9871,054,093891,59700000000000000000000000000000000
       Property Plant Equipment 
13,126
20,344
22,083
22,179
22,918
37,995
44,800
52,499
0
0
0
52,549
52,428
0
54,516
54,525
53,702
54,699
53,642
55,316
55,560
55,322
56,996
58,306
67,184
70,593
71,867
91,973
91,649
96,152
198,977
383,959
472,937
569,658
671,096
1,196,276
1,250,129
1,347,306
1,429,438
2,015,013
2,337,935
2,725,498
3,046,123
7,976,095
11,448,040
13,993,911
17,327,083
21,793,923
27,164,197
34,403,259
47,109,824
47,109,82434,403,25927,164,19721,793,92317,327,08313,993,91111,448,0407,976,0953,046,1232,725,4982,337,9352,015,0131,429,4381,347,3061,250,1291,196,276671,096569,658472,937383,959198,97796,15291,64991,97371,86770,59367,18458,30656,99655,32255,56055,31653,64254,69953,70254,52554,516052,42852,54900052,49944,80037,99522,91822,17922,08320,34413,126
       Goodwill 
0
0
0
0
0
0
0
40,438
0
0
0
31,420
30,973
0
30,079
29,632
29,184
28,737
28,290
31,420
31,420
31,420
31,420
31,420
31,420
31,420
39,783
32,339
32,248
32,609
33,121
143,669
178,636
193,533
221,859
245,929
287,113
304,512
328,063
300,277
409,657
449,661
486,155
531,171
610,307
712,137
864,545
1,017,397
1,233,327
1,525,164
2,058,835
2,058,8351,525,1641,233,3271,017,397864,545712,137610,307531,171486,155449,661409,657300,277328,063304,512287,113245,929221,859193,533178,636143,66933,12132,60932,24832,33939,78331,42031,42031,42031,42031,42031,42031,42028,29028,73729,18429,63230,079030,97331,42000040,4380000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,692
4,101
5,355
5,500
4,218
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004,2185,5005,3554,10111,6920000000000000000000000000000000
       Intangible Assets 
311
457
1,622
691
679
543
147
40,625
5,964
5,964
6,174
31,420
30,973
6,788
30,079
29,632
29,184
28,737
28,771
31,420
31,420
31,420
31,420
31,420
31,420
31,420
39,783
32,339
32,376
32,821
33,913
3,200
188,206
240,895
288,322
335,738
379,915
421,531
508,649
623,643
804,240
975,114
1,128,651
1,462,932
1,801,479
2,120,136
2,657,786
3,335,674
4,211,231
5,676,420
7,982,542
7,982,5425,676,4204,211,2313,335,6742,657,7862,120,1361,801,4791,462,9321,128,651975,114804,240623,643508,649421,531379,915335,738288,322240,895188,2063,20033,91332,82132,37632,33939,78331,42031,42031,42031,42031,42031,42031,42028,77128,73729,18429,63230,0796,78830,97331,4206,1745,9645,96440,6251475436796911,622457311
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
891,597
1,054,093
1,235,987
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,235,9871,054,093891,59700000000000000000000000000000000
> Total Liabilities 
48,610
64,334
71,342
68,621
74,108
90,962
108,921
178,942
185,468
185,468
207,433
196,336
235,531
243,608
274,160
292,642
299,363
300,866
303,726
436,712
460,578
540,743
605,060
671,672
549,419
625,695
715,969
864,588
911,607
1,130,640
1,616,125
1,594,256
1,669,514
1,731,410
2,369,968
3,034,658
3,051,279
3,443,970
4,275,481
4,752,830
5,500,623
8,099,865
19,838,051
20,317,526
19,620,716
23,084,085
24,298,693
30,502,686
35,074,179
44,365,456
59,845,703
59,845,70344,365,45635,074,17930,502,68624,298,69323,084,08519,620,71620,317,52619,838,0518,099,8655,500,6234,752,8304,275,4813,443,9703,051,2793,034,6582,369,9681,731,4101,669,5141,594,2561,616,1251,130,640911,607864,588715,969625,695549,419671,672605,060540,743460,578436,712303,726300,866299,363292,642274,160243,608235,531196,336207,433185,468185,468178,942108,92190,96274,10868,62171,34264,33448,610
   > Total Current Liabilities 
36,242
32,065
51,411
48,157
50,443
49,927
70,886
132,790
144,643
144,643
164,239
153,556
182,401
186,583
218,576
239,846
243,496
240,821
222,613
337,703
354,829
390,143
455,045
546,952
425,365
516,202
634,249
748,417
780,462
954,980
1,327,483
1,250,101
1,267,508
1,380,095
2,005,622
2,475,950
2,480,757
2,820,832
3,522,630
3,550,319
3,695,913
5,913,989
9,805,072
9,326,184
7,329,125
9,279,231
7,768,059
9,034,122
10,087,341
13,338,288
17,945,621
17,945,62113,338,28810,087,3419,034,1227,768,0599,279,2317,329,1259,326,1849,805,0725,913,9893,695,9133,550,3193,522,6302,820,8322,480,7572,475,9502,005,6221,380,0951,267,5081,250,1011,327,483954,980780,462748,417634,249516,202425,365546,952455,045390,143354,829337,703222,613240,821243,496239,846218,576186,583182,401153,556164,239144,643144,643132,79070,88649,92750,44348,15751,41132,06536,242
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
302,330
341,545
340,886
449,337
346,659
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000346,659449,337340,886341,545302,3300000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
302,330
341,545
340,886
449,337
346,659
325,998
566,163
987,993
659,873
632,373
1,871,833
2,090,837
1,788,036
1,550,121
2,146,245
2,337,427
2,858,241
3,710,779
5,106,602
5,790,879
5,790,8795,106,6023,710,7792,858,2412,337,4272,146,2451,550,1211,788,0362,090,8371,871,833632,373659,873987,993566,163325,998346,659449,337340,886341,545302,3300000000000000000000000000000000
       Accounts payable 
33,502
27,105
43,601
40,415
36,735
25,200
36,272
72,066
63,494
63,494
68,286
55,509
82,352
79,388
100,744
102,671
116,583
109,532
105,153
161,772
177,376
189,468
195,173
225,076
190,964
280,531
365,272
375,389
373,387
530,682
833,245
857,549
854,992
967,806
1,428,534
1,861,857
1,905,383
2,028,514
2,226,285
2,360,382
2,721,935
3,739,832
6,263,583
5,724,387
4,051,809
5,322,342
4,050,455
4,786,692
5,354,720
7,007,160
10,339,408
10,339,4087,007,1605,354,7204,786,6924,050,4555,322,3424,051,8095,724,3876,263,5833,739,8322,721,9352,360,3822,226,2852,028,5141,905,3831,861,8571,428,534967,806854,992857,549833,245530,682373,387375,389365,272280,531190,964225,076195,173189,468177,376161,772105,153109,532116,583102,671100,74479,38882,35255,50968,28663,49463,49472,06636,27225,20036,73540,41543,60127,10533,502
       Other Current Liabilities 
540
2,308
3,001
2,862
2,442
4,252
7,325
15,221
20,912
20,912
17,560
11,919
13,022
14,132
15,077
19,240
18,811
24,886
20,877
36,280
51,298
52,763
59,489
114,519
63,502
78,660
68,825
100,418
102,432
70,939
119,724
22,193
8
8,504
11,529
51,563
78,576
108,638
147,153
159,442
73,729
83,902
92,093
314,716
326,170
453,281
182,535
172,717
110,677
180,704
73
73180,704110,677172,717182,535453,281326,170314,71692,09383,90273,729159,442147,153108,63878,57651,56311,5298,504822,193119,72470,939102,432100,41868,82578,66063,502114,51959,48952,76351,29836,28020,87724,88618,81119,24015,07714,13213,02211,91917,56020,91220,91215,2217,3254,2522,4422,8623,0012,308540
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
402,006
351,315
364,345
558,708
570,522
623,138
752,851
1,486,170
1,804,710
2,185,876
10,032,979
10,991,342
12,291,590
13,804,853
16,530,634
21,468,563
24,986,838
31,027,168
41,900,082
41,900,08231,027,16824,986,83821,468,56316,530,63413,804,85312,291,59010,991,34210,032,9792,185,8761,804,7101,486,170752,851623,138570,522558,708364,345351,315402,00600000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-302,330
-341,545
-340,886
-449,337
-315,521
73,061
72,111
68,712
31,771
5,854
18
25,484
146,125
147,144
154,524
170,176
190,451
207,659
175,324
216,890
216,890175,324207,659190,451170,176154,524147,144146,12525,484185,85431,77168,71272,11173,061-315,521-449,337-340,886-341,545-302,3300000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,408
68,459
93,506
44,112
6,437
7,036
7,598
13,238
22,032
22,925
11,825
12,302
13,297
12,503
14,712
17,696
20,861
25,630
34,895
34,89525,63020,86117,69614,71212,50313,29712,30211,82522,92522,03213,2387,5987,0366,43744,11293,50668,45969,40800000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,103
183,662
235,836
282,143
327,755
372,981
414,059
501,529
647,600
796,149
967,297
1,120,985
1,454,967
1,792,758
2,107,607
2,632,992
3,261,103
4,087,482
5,451,190
0
05,451,1904,087,4823,261,1032,632,9922,107,6071,792,7581,454,9671,120,985967,297796,149647,600501,529414,059372,981327,755282,143235,836183,662140,1030000000000000000000000000000000
> Total Stockholder Equity
7,746
13,245
29,288
38,381
53,727
44,815
50,110
91,953
91,274
91,274
83,253
91,036
79,560
79,941
83,447
93,016
87,937
90,839
97,089
96,121
95,976
99,540
119,858
189,460
176,834
153,454
196,421
688,053
708,993
667,279
709,077
1,051,302
1,105,404
1,181,850
1,389,902
2,050,207
2,155,494
2,347,810
2,655,308
3,380,506
3,681,875
3,990,315
4,245,571
5,293,621
6,350,584
7,714,700
9,144,791
10,090,176
12,349,198
14,377,543
17,383,521
17,383,52114,377,54312,349,19810,090,1769,144,7917,714,7006,350,5845,293,6214,245,5713,990,3153,681,8753,380,5062,655,3082,347,8102,155,4942,050,2071,389,9021,181,8501,105,4041,051,302709,077667,279708,993688,053196,421153,454176,834189,460119,85899,54095,97696,12197,08990,83987,93793,01683,44779,94179,56091,03683,25391,27491,27491,95350,11044,81553,72738,38129,28813,2457,746
   Common Stock
133
2,822
2,822
3,642
3,642
27,254
27,254
27,254
66,584
66,584
66,584
27,254
27,254
66,584
27,254
27,254
27,254
27,254
27,254
27,254
27,254
27,254
27,254
27,254
66,584
66,584
66,584
80,752
80,752
80,752
80,752
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
80,751
0
080,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75180,75280,75280,75280,75266,58466,58466,58427,25427,25427,25427,25427,25427,25427,25427,25427,25427,25466,58427,25427,25466,58466,58466,58427,25427,25427,2543,6423,6422,8222,822133
   Retained Earnings 
7,429
10,423
10,966
12,265
14,519
17,561
22,856
25,369
24,690
24,690
16,669
24,452
12,975
13,356
16,863
26,432
21,352
24,255
30,504
29,537
29,392
32,956
53,273
122,876
110,250
86,870
103,289
115,573
135,917
83,834
89,372
-71,520
-338,266
-368,480
-388,342
6,420
-12,206
36,813
172,675
494,981
459,822
545,360
518,403
1,278,729
1,708,081
2,318,863
2,654,861
2,435,400
273,652
2,784,061
-3,238,108
-3,238,1082,784,061273,6522,435,4002,654,8612,318,8631,708,0811,278,729518,403545,360459,822494,981172,67536,813-12,2066,420-388,342-368,480-338,266-71,52089,37283,834135,917115,573103,28986,870110,250122,87653,27332,95629,39229,53730,50424,25521,35226,43216,86313,35612,97524,45216,66924,69024,69025,36922,85617,56114,51912,26510,96610,4237,429
   Capital Surplus 000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
316,146
361,582
373,046
463,986
846,328
883,139
961,737
1,036,270
1,284,478
1,424,085
1,458,905
1,564,253
1,639,383
1,898,233
2,190,727
2,598,195
3,103,994
3,787,605
4,777,230
0
04,777,2303,787,6053,103,9942,598,1952,190,7271,898,2331,639,3831,564,2531,458,9051,424,0851,284,4781,036,270961,737883,139846,328463,986373,046361,582316,1460000000000000000000000000000000



Balance Sheet

Currency in ARS. All numbers in thousands.




Cash Flow

Currency in ARS. All numbers in thousands.




Income Statement

Currency in ARS. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,461,102
Cost of Revenue-3,589,385
Gross Profit4,871,7174,871,717
 
Operating Income (+$)
Gross Profit4,871,717
Operating Expense-8,916,205
Operating Income-455,103-4,044,488
 
Operating Expense (+$)
Research Development-
Selling General Administrative2,494,445
Selling And Marketing Expenses-
Operating Expense8,916,2052,494,445
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,797,525
Other Finance Cost-0
Net Interest Income-1,797,525
 
Pretax Income (+$)
Operating Income-455,103
Net Interest Income-1,797,525
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,100,037-455,103
EBIT - interestExpense = -1,797,525
-4,785,221
-2,987,696
Interest Expense1,797,525
Earnings Before Interest and Taxes (EBIT)--4,302,512
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-6,100,037
Tax Provision--1,285,226
Net Income From Continuing Ops-4,814,811-4,814,811
Net Income-4,785,221
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,797,525
 

Technical Analysis of Laboratorios Richmond SACIF
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Laboratorios Richmond SACIF. The general trend of Laboratorios Richmond SACIF is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Laboratorios Richmond SACIF's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Laboratorios Richmond SACIF.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 860.50 < 945.00 < 1,235.

The bearish price targets are: 750.00 > 720.00 > 664.00.

Tweet this
Laboratorios Richmond SACIF Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Laboratorios Richmond SACIF. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Laboratorios Richmond SACIF Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Laboratorios Richmond SACIF. The current macd is -10.63497962.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laboratorios Richmond SACIF price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Laboratorios Richmond SACIF. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Laboratorios Richmond SACIF price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Laboratorios Richmond SACIF Daily Moving Average Convergence/Divergence (MACD) ChartLaboratorios Richmond SACIF Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Laboratorios Richmond SACIF. The current adx is 12.63.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Laboratorios Richmond SACIF shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Laboratorios Richmond SACIF Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Laboratorios Richmond SACIF. The current sar is 761.16.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Laboratorios Richmond SACIF Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Laboratorios Richmond SACIF. The current rsi is 49.15. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Laboratorios Richmond SACIF Daily Relative Strength Index (RSI) ChartLaboratorios Richmond SACIF Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Laboratorios Richmond SACIF. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laboratorios Richmond SACIF price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Laboratorios Richmond SACIF Daily Stochastic Oscillator ChartLaboratorios Richmond SACIF Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Laboratorios Richmond SACIF. The current cci is 73.45.

Laboratorios Richmond SACIF Daily Commodity Channel Index (CCI) ChartLaboratorios Richmond SACIF Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Laboratorios Richmond SACIF. The current cmo is 3.2667946.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Laboratorios Richmond SACIF Daily Chande Momentum Oscillator (CMO) ChartLaboratorios Richmond SACIF Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Laboratorios Richmond SACIF. The current willr is -48.97435897.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Laboratorios Richmond SACIF is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Laboratorios Richmond SACIF Daily Williams %R ChartLaboratorios Richmond SACIF Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Laboratorios Richmond SACIF.

Laboratorios Richmond SACIF Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Laboratorios Richmond SACIF. The current atr is 62.38.

Laboratorios Richmond SACIF Daily Average True Range (ATR) ChartLaboratorios Richmond SACIF Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Laboratorios Richmond SACIF. The current obv is 595,603.

Laboratorios Richmond SACIF Daily On-Balance Volume (OBV) ChartLaboratorios Richmond SACIF Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Laboratorios Richmond SACIF. The current mfi is 51.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Laboratorios Richmond SACIF Daily Money Flow Index (MFI) ChartLaboratorios Richmond SACIF Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Laboratorios Richmond SACIF.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-03STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Laboratorios Richmond SACIF Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Laboratorios Richmond SACIF based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.150
Ma 20Greater thanMa 50826.775
Ma 50Greater thanMa 100910.120
Ma 100Greater thanMa 200810.475
OpenGreater thanClose854.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Laboratorios Richmond SACIF with someone you think should read this too:
  • Are you bullish or bearish on Laboratorios Richmond SACIF? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Laboratorios Richmond SACIF? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Laboratorios Richmond SACIF

I send you an email if I find something interesting about Laboratorios Richmond SACIF.


Comments

How you think about this?

Leave a comment

Stay informed about Laboratorios Richmond SACIF.

Receive notifications about Laboratorios Richmond SACIF in your mailbox!